Related Experiment Video
Updated: May 20, 2025

08:35
Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
Published on: May 29, 2021
4.9K
E-FTMap: A Protein Structure Based Pharmacophore Identification Server for Guiding Fragment Expansion.
Omeir Khan1, George Jones2, Dima Kozakov3
1Department of Chemistry, Boston University, Boston, MA 02215, United States.
Journal of Molecular Biology
|March 26, 2025
Summary
Fragment-based drug design (FBDD) uses E-FTMap to guide the expansion of small molecule fragments into potent drug leads. This automated web server identifies preferred binding regions within protein targets, enhancing drug discovery efficiency.
Area of Science:
- Computational chemistry
- Structural biology
- Drug discovery
Background:
- Fragment-based drug design (FBDD) involves screening small compounds that bind weakly to protein targets.
- Fragment hits require expansion into more potent compounds for higher binding affinities.
- Ligand binding preferences of target proteins are crucial for guiding fragment expansion strategies.
Purpose of the Study:
- To introduce E-FTMap, an automated web server for identifying pharmacophore binding regions.
- To demonstrate E-FTMap's utility in guiding fragment expansion for improved drug potency.
- To provide a computational tool for structure-based drug design.
Main Methods:
- E-FTMap distributes 119 small organic probes across a protein's binding site.
- The server identifies energy minima and clusters probes by atom type to reveal binding preferences.
- FTMap server can identify binding hot spots if the binding site is not initially known.
Main Results:
- E-FTMap successfully identified important pharmacophore binding regions for 17 different protein targets.
- The protocol demonstrated effective guidance for expanding fragment hits into higher affinity binders.
- The E-FTMap web server provides atom-specific binding information based on protein structure alone.
Conclusions:
- E-FTMap is a valuable tool for structure-based fragment expansion in drug discovery.
- The automated protocol enhances the efficiency of developing potent drug leads from fragment hits.
- E-FTMap facilitates rational drug design by revealing specific ligand-protein interactions.

